IDEXX Laboratories, Inc. (LON:0J8P)

Market Cap	34.55B
Revenue (ttm)	3.04B
Net Income (ttm)	692.69M
Shares Out	n/a
EPS (ttm)	8.37
PE Ratio	49.88
Forward PE	45.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	235
Average Volume	154
Open	568.90
Previous Close	569.27
Day's Range	567.00 - 574.64
52-Week Range	351.94 - 574.64
Beta	1.54
RSI	73.27
Earnings Date	Aug 4, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1983
• Employees: 11,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J8P

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD